Melanoma incidence and survival in patients with myelodysplastic syndrome: A matched cohort population-based study

J Am Acad Dermatol. 2021 Feb;84(2):502-505. doi: 10.1016/j.jaad.2020.04.148. Epub 2020 May 4.

Authors

Paola Barriera-Silvestrini¹, David D Xiong², Steven Lewis³, Thomas Knackstedt⁴

Affiliations

¹ Department of Dermatology, MetroHealth System, Cleveland, Ohio.
² Department of Dermatology, MetroHealth System, Cleveland, Ohio; Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio.
³ Center for Health Care Research & Policy, MetroHealth System, Cleveland, Ohio.
⁴ Department of Dermatology, MetroHealth System, Cleveland, Ohio; School of Medicine, Case Western Reserve University, Cleveland, Ohio. Electronic address: [email protected].

PMID: 32376434
DOI: 10.1016/j.jaad.2020.04.148

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Case-Control Studies
Female
Humans
Incidence
Kaplan-Meier Estimate
Male
Melanoma / diagnosis
Melanoma / epidemiology*
Middle Aged
Myelodysplastic Syndromes / mortality*
Neoplasm Staging
Neoplasms, Second Primary / diagnosis
Neoplasms, Second Primary / epidemiology*
Risk Assessment / statistics & numerical data
SEER Program / statistics & numerical data
Skin Neoplasms / diagnosis
Skin Neoplasms / epidemiology*
Survival Rate
Young Adult